| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
| 9,075 |
-
| | | Gross Profit |
-
| (9,075) |
-
| | | Operating Expenses | | Research Development | 17,401 | 12,861 | 5,246 | | Selling General and Administrative | 6,770 | 2,562 | 4,525 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| 69 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (24,171) | (24,567) | (9,771) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,757 | 2,086 | 344 | | Earnings Before Interest And Taxes | (22,414) | (22,481) | (9,427) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (22,414) | (22,481) | (9,427) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,414) | (22,481) | (9,427) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 37 | | Other Items |
-
|
-
|
-
| | | | Net Income | (22,414) | (22,481) | (9,390) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,414) | ($22,481) | ($9,390) |
|
0.34% Nasdaq 0.00%
Income Statement
